is insufficient for the detection of this metabolite. Using the bute to safrole exposure in human beings (420 µM safrole 32 P-post-labeling technique, the most sensitive method for in saliva). Safrole is a known rodent hepatocarcinogen, yet detection of DNA adducts (11), stable safrole-DNA adducts its carcinogenicity in human beings is largely undetermined.
unstable sulfuric acid ester that reacts to form stable safrole-11217, Republic of China DNA adducts (9) . 1Ј-Hydroxysafrole, the proximate carcinogen Email: tyliu@vghtpe.gov.tw of safrole, was detected in the liver, urine and bile of animals Betel quid (BQ) chewing has been associated with an treated with safrole (8) . However, 1Ј-hydroxysafrole was not increased risk of oral squamous cell carcinoma (OSCC) detected in human subjects who received 1.66 mg [ 14 C]safrole and oral submucous fibrosis (OSF). Piper betle inflores- (10) . The reason for this discrepancy remains unknown. It is cence, which contains 15 mg/g safrole, is a unique ingredient plausible that the administrated dose or the assay sensitivity of BQ in Taiwan. Chewing such prepared BQ may contriis insufficient for the detection of this metabolite. Using the bute to safrole exposure in human beings (420 µM safrole 32 P-post-labeling technique, the most sensitive method for in saliva). Safrole is a known rodent hepatocarcinogen, yet detection of DNA adducts (11) , stable safrole-DNA adducts its carcinogenicity in human beings is largely undetermined.
can be detected in both rodent liver and other tissues treated In this study, using a 32 P-post-labeling method, we have with safrole (12) (13) (14) . However, the effect of safrole in human found a high frequency of safrole-like DNA adducts in beings has not been documented. In this study, using the 32 P-BQ-associated OSCC (77%, 23/30) and non-cancerous post-labeling technique, we determined the presence of safrolematched tissue (NCMT) (97%, 29/30). This was in contrast like DNA adducts in oral tissues of BQ users. to the absence (< 1/10 9 nucleotides) of such adducts in all Histologically confirmed OSCC (n ϭ 36) and OSF (n ϭ 7) of non-BQ-associated OSCC and their paired NCMT tissues were obtained from the Department of Dentistry, (P < 0.001). Six of seven OSF also exhibited the same according to a protocol approved by the committee for the safrole-like DNA adduct. The DNA adduct levels in OSF conduct of human research at the Veterans General Hospitaland NCMT were significantly higher than in OSCC Taipei. Specimens were kept at -70°C immediately after (P < 0.05). Using co-chromatography and rechromatoexcision until DNA extraction. History of BQ chewing, cigargraphy techniques, we further demonstrated that these ette smoking, alcohol consumption and other clinical paraadducts were identical to synthetic safrole-dGMP adducts meters were carefully recorded. Normal gingival tissues as well as DNA adducts from 1Ј-hydroxysafrole-treated (n ϭ 14) were obtained from healthy volunteers undergoing HepG2 cells. These results suggest that safrole forms stable tooth extraction. DNA was extracted by a conventional phenol/ safrole-DNA adducts in human oral tissue following BQ chloroform procedure (15). chewing, which may contribute to oral carcinogenesis.
1Ј-Hydroxysafrole was synthesized from vinyl bromide and piperonal (16). 1Ј-Hydroxysafrole was then reacted with 2Ј-deoxyguanosine 3Ј-monophosphate (dGMP) or 2Ј-deoxyadenosine 3Ј-monophosphate (dAMP) in the presence Oral squamous cell carcinoma (OSCC) is one of the most of sulfotransferase and 3Ј-phosphoadenosine 5Ј-phosphosulfate common malignant neoplasms in Asian countries. It is the (PAPS). The incubation mixture contained 3 mM MgCl 2 , 0.1 fifth leading cause of male cancer mortality in Taiwan (1) . mM PAPS, 5 mM dGMP or dAMP, hepatic cytosol from ICR The International Agency for Research on Cancer concluded mice (2 mg protein) and 4 mM 1Ј-hydroxysafrole in a final that OSCC is associated with betel quid (BQ) chewing together volume of 2 ml of 50 mM Tris-HCl buffer (pH 7.4). After with tobacco or cigarette smoking (2) . Oral submucous fibrosis incubation at 37°C for 3 h, 5-fold cold acetone was added and (OSF) is also a frequent precancerous condition in BQ chewers the mixture was centrifuged at 10 000 g at 4°C for 20 min. (3). In Taiwan, tobacco is not included in the preparation used
The supernatant was analyzed by the 32 P-post-labeling assay. for BQ chewing. Nevertheless, epidemiological studies showed HepG2 cells were first cultured in DMEM medium containing that BQ chewing is still the main cause of OSCC and OSF in 10% fetal bovine serum, then changed to serum-free medium Taiwan (4, 5) . The most popular way to chew BQ in Taiwan and incubated with 400 µM 1Ј-hydroxysafrole for 24 h prior is a combination of the areca nut, Piper betle inflorescence to adduct analysis. (sometimes substituted by betel leaf) and lime paste. Piper Four micrograms of coded DNA samples were assayed by the nuclease P1-enhanced 32 P-post-labeling procedure as safrole-DNA adducts were resolved on polyethyleneimine-cellulose TLC plates (Machery-Nagel, Düren, Germany) with two different buffer systems. Development condition A consisted of 2.3 M sodium phosphate, pH 6.0 (D1) and 1.8 M lithium formate, 4.25 M urea, pH 3.5 (D2) (bottom to top); 0.36 M lithium chloride, 0.22 M Tris-HCl, 3.8 M urea, pH 8.0 (D3) and 1.7 M sodium phosphate, pH 6.0 (D4) (left to right). Safrole-DNA adducts were detected by autoradiography and quantified by scintillation counting. Adduct levels are expressed as relative adduct labeling (RAL)ϫ10 8 values (11) . The sensitivity of this assay was limited to 1 adduct/10 9 nucleotides. To compare the adducts detected in OSCC with safrole-DNA adducts in 1Ј-hydroxysafrole-treated HepG2 cells, the two DNA samples were mixed before enzymatic digestion and, using the above-mentioned condition A, the resulting chromatogram was compared with maps derived from individual DNA samples. These adducts were also compared by a different development condition designated condition B: 1.7 M sodium phosphate, pH 6.0 (D1); 1.9 M lithium formate, 3.8 M urea, pH 3.5 (D2); 0.36 M sodium phosphate, 0.23 M Tris-HCl, pH 8.0 (D3); 1.7 M sodium phosphate, pH 6.0 (D4) (17). To further characterize these adducts, excised adducts from individual chromatograms were extracted with 4 N Thirty-six patients with OSCC were enrolled in this study.
were visualized by autoradiography employing Kodak Biomas MR imaging
The sex difference (34 males, two females) closely resembles film with an intensifying screen for 24 h at -70°C, except for (A), which the distribution of BQ chewers (21:1) in the Taiwanese was exposed for 6 h. population (20). The most common primary site of OSCC was the buccal mucosa (14 cases) followed by the tongue (seven cases) and gingiva (five cases). The majority of BQ chewers of such adducts with safrole-DNA adducts 1 and 2 was demonstrable under development condition B (data not shown). (30 cases) were also cigarette smokers (27 cases). Seven male patients with OSF were also included in this study, all of To characterize these adducts further, we reacted dGMP and dAMP with 1Ј-hydroxysafrole and separated the products in a whom were BQ chewers and cigarette smokers.
We detected two major and two minor DNA adducts on TLC plate using development condition B (Figure 2A and D) . As shown in Figure 2C and F, the adduct product co-migrated autoradiograms from 1Ј-hydroxysafrole-treated HepG2 cells under condition A ( Figure 1A) . The levels of spot 1 and spot with adduct 1 obtained from safrole-dGMP, but not with dAMP derivatives (spot 5). The nature of spots 1 and 2 in 2 were 105.0 and 22.3 adducts/10 8 nucleotides, respectively. This map was qualitatively similar to DNA adducts found in OSCC were further demonstrated to be identical to the 1Ј-hydroxysafrole-treated DNA adducts by two different solvent safrole-treated mice as described by Reddy and Randerath (13). The two major safrole-DNA adducts have been identified systems in 1-dimensional TLC (Figure 3 ). The major (spot 1) and minor (spot 2) adducts were confirmed as chromatographicas N 2 -(trans-isosafrol-3Ј-yl) 2Ј-deoxyguanosine (spot 1) and N 2 -(safrol-1Ј-yl) 2Ј-deoxyguanosine (spot 2) (21). The nature ally indistinguishable from safrole-dGMP adducts using two distinct development conditions, co-chromatography and of the two minor safrole-DNA adducts (spots 3 and 4) remains unclear. In this study, one major spot (spot 1) in the fingerprints rechromatography.
The safrole-like DNA adduct was present in 77% (23/30) of OSCC and non-cancerous matched tissue (NCMT) ( Figure  1B and C) as well as in OSF samples was detected. In addition, of OSCC, 97% (29/30) of NCMT from OSCC patients and 86% (6/7) of OSF patients with BQ use. In contrast, this one minor spot (spot 2) was occasionally noticed ( Figures 1C  and 2B and E) . The chromatographic location of this major safrole-like DNA adduct was not detectable in gingival tissues from 14 persons without BQ chewing. The presence of this DNA adduct is qualitatively similar to spot 1 as shown by others (12) (13) (14) . On the other hand, no adduct was detectable adduct in oral samples is highly correlated with BQ chewing (Fisher's exact test, P Ͻ 0.001). The safrole-like DNA adduct on the autoradiogram of the control gingival sample ( Figure  1D ). The location of the major DNA adducts in oral tissues levels in OSCC, NCMT and OSF were 4.0 Ϯ 0.9 (range 0-19.4), 9.7 Ϯ 2.7 (range 0-65.3) and 7.8 Ϯ 1.5 (range 0-11.7) was qualitatively similar to that of the safrole-DNA adduct (spot 1) from 1Ј-hydroxysafrole-treated HepG2 cells ( Figure  per 10 8 nucleotides, respectively (Table I ). The DNA adduct levels in OSF and NCMT were significantly higher than that 1A). In this development system, interference by benzo [a] pyrene and other macromolecular DNA adducts which result in OSCC (Mann-Whitney rank sum test, P Ͻ 0.05). The formation of covalent adducts of DNA is generally from cigarette smoking was unlikely since these adducts are much more hydrophobic than safrole adducts (data not shown).
regarded as a critical event in the initiation of chemical carcinogenesis. Consequently, measurement of DNA adducts In order to identify the nature of the DNA adducts, DNA from OSCC was mixed with 1Ј-hydroxysafrole-treated HepG2 may be a powerful tool to demonstrate a possible association between carcinogen exposure and cancer risk. The 32 P-post-DNA, then digested and developed in TLC plates. Under condition A, the major and minor spots co-migrated with labeling assay combined with the nuclease P1 enhancement technique provides a highly sensitive method for detecting safrole-DNA adducts 1 and 2 (spots 1 and 2). Co-migration Safrole-like DNA adducts in oral tissues The sensitivity of this assay is 1/10 9 nucleotides and adduct levels below the limit of detection are represented by 0. Chromatographs were developed under condition B. Autoradiographs were obtained after 24 h at -70°C, except for (A), which was exposed for 10 h. DNA repair (12) . In this study, we detected one major and/or one minor adduct in oral tissues instead of four spots as seen in 1Ј-hydroxysafrole-treated HepG2 cells and mice hepatic and pharmacokinetic factors, adduct stability and the rates of cell turnover and DNA repair. Substantial amounts of safroletissues. There may be a number of reasons for this difference. First, adduct 1 forms more easily than other adducts. Second, like DNA adducts were detected in most of the BQ-associated subjects and the levels of safrole-like DNA adducts were adduct 1 is resistant to repair processes. Last, safrole requires a two-step metabolic activation to form DNA adducts and the significantly higher in NCMT than in OSCC. Observations of a higher carcinogen-DNA adduct level in NCMT rather than metabolic capacity of oral tissue is lower than that of liver tissue. Consequently, the major adduct levels are lower and tumors has been reported in lung, colorectal and breast cancer (18,22,23). A tentative explanation for this phenomenon is the minor adducts are not detectable in oral tissues.
Adduct levels in a cell are dependent on pharmacodynamic that the level of DNA adducts may have been diluted during treated with safrole, estragole and other naturally-occurring rapid DNA replication and tumor cell turnover. Another 
